Convocation of the general shareholders meeting of VILNIAUS BALDAI ABConvocation of the general shareholders meeting of VILNIAUS BALDAI AB GlobeNewswire
||
On the initiative and decision of the Company’s Management Board the Ordinary General Shareholders Meeting of VILNIAUS BALDAI AB (identification code 121922783, address Pramonės st. 23, Guopstų vil., Trakų... 
FluidForm Bio™ Announces Participation in the New England Venture SummitFluidForm Bio™ Announces Participation in the New England Venture Summit GlobeNewswire
||
WALTHAM, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) — FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO... 
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in JapanVerrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan GlobeNewswire
||
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical... 
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct OfferingEyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering GlobeNewswire
||
NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet... 
Genius Group acquires Bitcoin Learning Platform, XD AcademyGenius Group acquires Bitcoin Learning Platform, XD Academy GlobeNewswire
||
SINGAPORE, Dec. 06, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it has... 
Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute LeukemiaBiomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia GlobeNewswire
||
REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to... 
Sustainability Roundtable, Inc. Causes 1 Gigawatt of New Renewable Energy Development through “VPPA 2.0”Sustainability Roundtable, Inc. Causes 1 Gigawatt of New Renewable Energy Development through “VPPA 2.0” GlobeNewswire
||
SR Inc’s Net Zero Consortium for Buyers embraces exponential growth and sets a new goal for Advance Market Commitments to help NZCB Members cause a total of 10 Gigawatts... Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 GlobeNewswire
||
Celularity filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024, and is now current with its quarterly report filings Reported Total Net Revenue for the... 
The Conference Board of Canada: Aggressive Immigration Policy to Slow GrowthThe Conference Board of Canada: Aggressive Immigration Policy to Slow Growth GlobeNewswire
||
OTTAWA, Ontario, Dec. 06, 2024 (GLOBE NEWSWIRE) — The federal government’s revised immigration policy, which aims to dramatically reduce the number of non-permanent residents in Canada, will significantly slow... 
Synergy CHC Reports its Seventh Consecutive Quarter of Profitability and its Third Quarter 2024 Financial ResultsSynergy CHC Reports its Seventh Consecutive Quarter of Profitability and its Third Quarter 2024 Financial Results GlobeNewswire
||
WESTBROOK, Maine, Dec. 06, 2024 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today its...